Similar to the findings of CAPPP and ASCOT-BPLA, the ALLHAT demonstrated an ACE inhibitor’s superiority over thiazides in reducing the rate of new-onset diabetes. However, the trial did note ...

In the 4 eligible trials (the ABCD trial, the CAPPP, the FACET, and the UKPDS), the total number of participants was 2,180 (1,133 randomized to an ACE inhibitor and ...

Diabetes is the leading cause of kidney failure ... other treatments for disease management such as medicines to manage blood ...

myocardial infarction and kidney problems caused by diabetes. This medication is an ACE (angiotensin-converting enzyme) inhibitor, prescribed for high blood pressure either alone or with other ...

The first step in managing diabetes and high blood pressure is adopting a healthy diet. A diet rich in fruits, vegetables, ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

A recent study suggests that a commonly prescribed type of blood pressure medication, known as angiotensin receptor blockers ...

Use of angiotensin-converting-enzyme inhibitors has been associated with an increased risk of developing the chronic pain condition, which suggests possible roles for substance P and bradykinin in ...

Diabetes is the leading cause of kidney failure ... management such as medicines to manage blood pressure, including ACE inhibitors and ARBs. About 3,500 adults across 28 countries were enrolled ...

For patients who are intolerant of ACE inhibitors, alternative medications are available. The combination of hydralazine and nitrates also decreases mortality for patients with systolic ...